Bristol-Myers swings the ax
Bristol-Myers Squibb (BMY) is swinging the ax. The big pharmaceuticals company said Wednesday it will cut 10% of its staff in what it grandly calls a “productivity transformation initiative.” The firings and related moves will save Bristol $1.5 billion annually by 2010, the company says. In cutting back Bristol-Myers joins rivals such as Pfizer (PFE), which earlier this year set plans to cut 10,000 jobs, and Johnson & Johnson (JNJ), which has targeted 5,000 job cuts. A 10% cut at Bristol-Myers should mean the loss of about 4,300 jobs, going by figures on Yahoo! Finance.
Bristol is also dropping some businesses that don’t fit with its new focus on becoming what it calls “a next-generation BioPharma company,” and says it plans on making more strategic acquisitions in specialty medicines and biologics. So far, Wall Street is unimpressed: Shares dropped 1% in midday trading.
- So the Citi deal backed by the FDIC w... More
- This is why Government should only do... More
- I am a big fan of Buffet, but at the... More
- Miller - you are a fool. GE employs 3... More
- Treat the employees like sh!t and wha... More
- As a homeowner (barely), I should hav... More
- I wonder if there will ever be any tr... More
- Gifting WB to citi was a rip off of t... More
- If it dipped 15%, Buffett will probab... More
- Why is citi spending money on somethi... More
- Accrued Interest
- Aleph Blog
- Bespoke Investment Group
- Big Picture
- Calculated Risk
- Dealbook
- Econbrowser
- Felix Salmon
- Financial Armageddon
- Footnoted
- FT Alphaville
- Infectious Greed
- Naked Capitalism
- RGE Monitor
- Seeking Alpha
- Information Arbitrage
- Mish's Global Economic Trend Analysis
- Fortune on CNNMoney.com




